Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer

International Journal of Biological Markers

Volumn 15, Issue 1, 2000, Pages 22-25

  Lissoni, P ^c   Brivio, F ^c   Ferrante, R ^a   Vigore, L ^a   Vaghi, M ^c   Fumagalli, E ^c   Bucovec, R ^c   Malugani, F ^c   Fumagalli, L ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b CHIRON VACCINES   (Italy)

^c NONE

Author keywords

Dendritic cells; Immunosuppression; Interleukin 2; Lymphocyte subsets

Indexed keywords

ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CELL COUNT; CELL MATURATION; CLINICAL ARTICLE; DENDRITIC CELL; DIGESTIVE SYSTEM CANCER; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MALE; METASTASIS; NATURAL KILLER CELL; T LYMPHOCYTE;

EID: 0034110554     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080001500104     Document Type: Article

References (12)

1. Atzpodien J, Kirchner H. Cancer, cytokines and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms. Klin Wochenschr 1990; 68: 1-11.
2. Riesco A. Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer 1970; 25: 135-40.
3. Maltoni M, Privano M, Nanni O, et al. Biological indices predictive of survival in 519 Italian terminally ill cancer patients. J Pain Symptom Manage 1997; 13: 1-9.
4. Lissoni P, Fumagalli L, Paolorosi F, Mandalà M. Changes in lymphocyte number during cancer chemotherapy and their relation to the clinical response. Int J Biol Markers 1999; 14: 115-7.
5. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. J Exp Med 1982; 155: 1823-41.
6. Lotze MT, Hellerstedt B, Stolinski L, et al. The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy. Cancer J Sci Am 1997; 3: S109-14.
7. Wanebo HJ, Pace R, Hargett S, Katz D, Sando J. Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients. Cancer 1986; 57: 656-62.
8. Lissoni P, Barni S, Rovelli F, et al. Correlations of serum interleukin-2 levels, soluble interleukin-2 receptors and T lymphocyte subsets in cancer patients. Tumori 1990; 76: 14-17.
9. Savary CA, Grazziutti ML, Melichar B, et al. Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients. Cancer Immunol Immunother 1998; 45: 234-40.
10. Di Nicola M, Anichini A, Mortarini R, et al. Human dendritic cells: natural adjuvants in antitumor immunotherapy. Cytok Cell Mole Ther 1998; 4: 265-73.
11. Lissoni P, Vigoré L, Ferrante R, et al. Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease. J Biol Regul Homeost Agents, in press.
12. O'Doherty U, Peng M, Gezelter S, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994; 82: 487-93.